Popular on Amzeal
- AI is marmite. Parents about to spread it anyway - 209
- New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors - 199
- CasaPerks and CredHub Partner to Help the Multifamily Industry Strengthen Resident Activation Through Credit-Building Rewards - 181
- New Book Helps Educators Navigate AI in the Classroom While Keeping Humans in Charge - 164
- Sales Blueprint Architect Launches, Helping Sales Professionals, Business Owners, and Consultants Close More Business With AI - 143
- KMTEKLED Strengthens Local Support in the U.S. and Europe with Regional Warehouses and Offices - 138
- FoodNiche Health Forum to Convene Community Leaders for High-Impact Collaboration and Knowledge Exchange - 138
- Arizona Technology Council to Host 11th Annual Cybersecurity Breakfast Forum - 120
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 114
- Dana Flanagan Expands the Authority Architect, Bringing a Nontraditional Approach to Executive Authority, Strategic Access and Business Growth
Similar on Amzeal
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- 360 Sound And Vision, 3D Dreams And Filmmaker Dwayne Buckle Unveil First Official Posters For The Glasses 3D
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Aerostratospheric Adds xAirship and Other Shop Test Units to Its xPrototypes Bench
Lineus Medical Elevates Leadership to Accelerate Growth After Breakthrough Clinical Results
Amzeal News/10638555
FAYETTEVILLE, Ark. - Amzeal -- Lineus Medical, maker of SafeBreak Vascular, has seen breakthrough clinical results at multiple hospital systems across the U.S. that validate the clinical and health-economic value proposition for SafeBreak, the first breakaway device for IV lines.
The cumulative data, cultivated through evidence-based medicine and demonstrated across tens of thousands of patients, is convincing and has clearly demonstrated SafeBreak's value, use, and adoption as a true standard of care. Based on the clinical success seen to date, additional capital has been raised to accelerate commercial efforts in the U.S., Europe, Latin America, and Asia.
To support this growth, the company has promoted Larry Hayes to President and Chief Commercial Officer. In his expanded role, Larry will oversee the company's marketing, sales, manufacturing, and human resources functions, consolidating operational leadership under a single point of accountability as Lineus scales its commercial operations.
More on Amzeal News
"I'm honored to take on this role at such a pivotal moment for Lineus Medical. We have built tremendous momentum over the past year. Stepping into this role, alongside my commercial responsibilities, gives me a broader hand in how we scale our growth long-term. We're not changing direction, we're accelerating it," said Hayes.
"This new leadership structure, alongside recent investments, reflects the confidence we have in Lineus Medical's trajectory. Larry has been instrumental in establishing Lineus' Clinical Evidence Program through the Breakaway Impact Registry, a key to the company's commercial success. This expanded role positions Larry to help lead our next stage of growth," said Jonathon Fite, Chairman of the Board.
CEO and co-founder, Vance Clement, will continue to lead the company with a renewed passion on next generation vascular access solutions. "I am excited to focus on the long-term future of Lineus Medical and the scientific advancement of our intellectual property and product portfolio," said Vance Clement.
More on Amzeal News
Additionally, Lineus announces the appointment of Pravin Raj to its Board of Directors. Mr. Raj's services and technology background to help organizations scale will complement the company's near-term commercialization and long-term portfolio development goals.
SafeBreak Vascular is a breakaway device for IV lines that separates when a damaging force is applied to IV lines, removing the damaging forces and protecting the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump, and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44%-91%.1 The device is FDA-cleared for use across all vascular lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical
Lineus Medical is the developer of SafeBreak Vascular, a breakaway technology proven to reduce IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical for more on LinkedIn, Facebook, and Instagram.
Reference:
1. Data on File.
The cumulative data, cultivated through evidence-based medicine and demonstrated across tens of thousands of patients, is convincing and has clearly demonstrated SafeBreak's value, use, and adoption as a true standard of care. Based on the clinical success seen to date, additional capital has been raised to accelerate commercial efforts in the U.S., Europe, Latin America, and Asia.
To support this growth, the company has promoted Larry Hayes to President and Chief Commercial Officer. In his expanded role, Larry will oversee the company's marketing, sales, manufacturing, and human resources functions, consolidating operational leadership under a single point of accountability as Lineus scales its commercial operations.
More on Amzeal News
- 360 Sound And Vision, 3D Dreams And Filmmaker Dwayne Buckle Unveil First Official Posters For The Glasses 3D
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
"I'm honored to take on this role at such a pivotal moment for Lineus Medical. We have built tremendous momentum over the past year. Stepping into this role, alongside my commercial responsibilities, gives me a broader hand in how we scale our growth long-term. We're not changing direction, we're accelerating it," said Hayes.
"This new leadership structure, alongside recent investments, reflects the confidence we have in Lineus Medical's trajectory. Larry has been instrumental in establishing Lineus' Clinical Evidence Program through the Breakaway Impact Registry, a key to the company's commercial success. This expanded role positions Larry to help lead our next stage of growth," said Jonathon Fite, Chairman of the Board.
CEO and co-founder, Vance Clement, will continue to lead the company with a renewed passion on next generation vascular access solutions. "I am excited to focus on the long-term future of Lineus Medical and the scientific advancement of our intellectual property and product portfolio," said Vance Clement.
More on Amzeal News
- 12th Annual iMIS® Membership Benchmark Survey Now Open: Global Association and Non-Profit Professionals Invited to Share 2027 Trends
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
- TBM Council Establishes TBM as The Business Operating System for AI
- Greyhaven Group Introduces AI-Ready Infrastructure Services for Growing Businesses
Additionally, Lineus announces the appointment of Pravin Raj to its Board of Directors. Mr. Raj's services and technology background to help organizations scale will complement the company's near-term commercialization and long-term portfolio development goals.
SafeBreak Vascular is a breakaway device for IV lines that separates when a damaging force is applied to IV lines, removing the damaging forces and protecting the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump, and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44%-91%.1 The device is FDA-cleared for use across all vascular lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical
Lineus Medical is the developer of SafeBreak Vascular, a breakaway technology proven to reduce IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical for more on LinkedIn, Facebook, and Instagram.
Reference:
1. Data on File.
Source: Lineus Medical
0 Comments
Latest on Amzeal News
- 32-inch Touchscreen Display ramps up game machine attraction
- Eber Technologies Launches Free AI Readiness Assessment for Businesses and Organizations
- Easy Speak Stories Launches Digital Storytelling Platform for Personal and Institutional Legacies
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- cXm Professionals Association Announces 2026 Industry Award Recipients for Customer Communications Innovation
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Boost Board Gives Daily Visibility to Fundraising Campaigns Stuck at Zero
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
- Your HealthTech Product Works but No one can find it
- Yonggui MCS Charging Connector and Vehicle Inlet Receive TÜV Rheinland Certification
- Anypin Note Pod P1 Redefines AI Voice Recording with Intelligent Transcription and Smart Note Taking
- Lake Norman Philharmonic - Free Community Concert
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
- AI Visibility Campaign by 1stpage Reaches 800+ Citations Across Major AI Platforms in Four Months
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
- Blue-Band Introduces IntegraOS™, the Operating System for Intelligent Infrastructure
- Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million



